Global Arthritis Market is Driven by Rising Cases of Rheumatoid Arthritis Worldwide

Arthritis Market is estimated to grow at substantial CAGR in the forecast period of 2019-2026 with factors such as high cost of hyaluronic acid products along with lack of effective treatment other than symptomatic mode for osteoarthritis which will impede the growth of the market in emerging economies.

Arthritis market has shown an exceptional penetration in developed economies in North America. Increasing prevalence of favorable reimbursement policies along with support of novel drugs which will likely to enhance the growth of the market.

Arthritis Market Scenario

According to Data Bridge Market Research the arthritis market is attaining a significant growth in developing economies during the forecast period of 2019-2026 due to factors such as increasing aging population, growing demand for minimally invasive procedures among population, increasing obesity among population, rising cases of rheumatoid arthritis which will help in boosting the growth of the market.

Now the question is which are the other regions that arthritis market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific arthritis market in the forecast period of 2019-2026. The Data bridge market research new reports highlight the major growth factors and opportunities in the arthritis market.

For more analysis on the arthritis market request for a briefing with our analysts

Scope of the Arthritis Market

Arthritis market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of the arthritis market is further analyzed based on maximum granularity into further segmentation. On the basis of rheumatoid drug type, the market is segmented into biologics, non-biologics, steroids, analgesics, glucocorticoids, and others. Based on rheumatoid diagnosis, the market is segmented into CRP Test, CCP, and ESR test. Based on rheumatoid treatment, the market is segmented into synovectomy, tendon repair, joint fusion, symptomatic treatment, intermediate corticosteroid therapies, and DMARD therapies. Based on osteoarthritis type, the market is segmented into hip, spinal, knee, foot and ankle, shoulder, and hand. Based on osteoarthritis diagnosis, the market is segmented into imaging, joint fluid analysis, and others. Based on osteoarthritis treatment, the market is segmented into medication, drugs, assistive devices, surgery, and therapy. Based on route of administration, the market is segmented into oral, and parenteral. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and drug stores. Based on end-users, the market is segmented into hospitals, clinics, household, medical institutes, research organizations, and others.
  • Arthritis, also known as joint inflammation, is characterized as tenderness or swelling occurring in patients' joints, with stiffness and pain in the joints being the symptoms of the disease. Rheumatoid arthritis and osteoarthritis are classified into the two most common variants.  

To know more about the study

Key Pointers Covered in the Arthritis Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • AbbVie Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • UCB S.A.
  • Gilead Sciences, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi
  • AstraZeneca
  • Astellas Pharma Inc.
  • Galapagos NV
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Boehringer Ingelheim GmbH
  • Swedish Orphan Biovitrum AB (publ)
  • Regeneron Pharmaceuticals
  • Abiogen Pharma Spa
  • Merck & Co., Inc.
  • Kolon TissueGene, Inc.
  • Ampio Pharmaceuticals Inc.
  • GlaxoSmithKline plc

Above are the key players covered in the report, to know about more and exhaustive list of arthritis companies, contact us

Research Methodology: Global Arthritis Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@